Page
Menu
  Sitemap

Welcome To Sweet Coconut Lime

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group..
. Packer M, et al. Eur J Heart Fail. 2021 Aug 30. doi: 10.1002/ejhf.2334. Online ahead of print. Eur J Heart Fail. 2021. PMID: 34459076.
.
Risk of Treatment Escalation in Recipients vs Nonrecipients of Spinal Manipulation for Musculoskeletal Cervical Spine Disorders: An Analysis of Insurance Claims.
Anderson BR, McClellan WS, Long CR.

top
Home
Page
Menu